Intelligent Bio Solutions Inc.
INBS
$2.47
$0.041.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -36.50% | -6.91% | 10.24% | 3.47% | -21.49% |
| Total Depreciation and Amortization | -0.76% | 3.02% | -7.09% | 1.03% | 1.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 325.20% | -156.14% | -77.74% | 48.66% | 30,722.22% |
| Change in Net Operating Assets | 118.86% | -331.63% | 227.75% | -289.64% | 159.91% |
| Cash from Operations | 26.52% | -176.27% | 44.94% | -28.81% | 19.79% |
| Capital Expenditure | -100.00% | 118.91% | 3.13% | 66.24% | -1,347.92% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -100.00% | 145.91% | 60.09% | 66.24% | -1,347.92% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -97.01% | 1,447.19% | -81.04% | 491.06% | -81.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -97.01% | 1,447.19% | -81.04% | 491.06% | -81.88% |
| Foreign Exchange rate Adjustments | -33.33% | -50.00% | 271.43% | -102.39% | 123.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -146.88% | 765.63% | -243.66% | 135.82% | -416.37% |